CFTR and cystic fibrosis: Mandatory screening for pathogenic mutations in the CFTR gene is necessary when planning pregnancy, conducting assisted reproductive technologies, and selecting sperm or blood donors, which seems to be the most effective way to identify heterozygous carriers and reduce the burden of CF in the population.